RELATIONSHIP OF FIBRINOLYSIS AND PLATELET-FUNCTION TO BLEEDING AFTER CARDIOPULMONARY BYPASS

被引:57
作者
RAY, MJ [1 ]
MARSH, NA [1 ]
HAWSON, GAT [1 ]
机构
[1] QUEENSLAND UNIV TECHNOL,SCH LIFE SCI,BRISBANE,QLD 4001,AUSTRALIA
关键词
FIBRINOLYSIS; TISSUE PLASMINOGEN ACTIVATOR; ALPHA(1)-ANTIPLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR-1; PLATELET FUNCTION; CARDIOPULMONARY BYPASS; BLOOD LOSS;
D O I
10.1097/00001721-199410000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to study the effects of cardiopulmonary bypass (CPB) on fibrinolysis and platelet function and the possible relationship of these effects on post-operative blood loss, 127 patients undergoing CPB were examined. There was a significant reduction in the median levels of fibrinogen, plasminogen, alpha(2)-antiplasmin, fibrinolytic potential and platelet aggregation during CPB (P less than or equal to 0.001). Median levels of soluble fibrin, fibrinogen degradation products, D-dimer and PAI-1 were increased, while the level of t-PA activity remained constant. Post-CPB levels of fibrinogen and plasminogen correlated negatively with blood loss (P=0.003 and P<0.001, respectively) and interestingly, lower levels of alpha(2)-antiplasmin and higher levels of t-PA activity before CPB were associated with greater blood loss after CPB (P<0.001 and P=0.004, respectively). Better pre-CPB platelet function correlated with lower levels of D-dimer before and after CPB. As expected, haemodilution had a significant effect on fibrinolytic and coagulation parameters post-CPB; the greater the haemodilution, the more the concentration of fibrinogen, plasminogen and alpha(2)-antiplasmin fell post-CPB and the greater the blood loss. The increase in PAI-1 levels intra-CPB appeared to result in mean t-PA activity remaining unchanged 1 h post-CPB. Post-CPB increases in soluble fibrin were paralleled by increases in fibrinogen degradation products and D-dimer, suggesting that intra-operative contact activation is related to activation of the fibrinolytic system. The present findings indicate the greater the fibrinolytic activation, the greater the post-CPB blood loss.
引用
收藏
页码:679 / 685
页数:7
相关论文
共 25 条
[1]   PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN PLASMA AND PLATELETS [J].
BOOTH, NA ;
SIMPSON, AJ ;
CROLL, A ;
BENNETT, B ;
MACGREGOR, IR .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 70 (03) :327-333
[2]   EVIDENCE FOR A RAPID INHIBITOR TO TISSUE PLASMINOGEN-ACTIVATOR IN PLASMA [J].
CHMIELEWSKA, J ;
RANBY, M ;
WIMAN, B .
THROMBOSIS RESEARCH, 1983, 31 (03) :427-436
[3]   IMMUNOHISTOLOGICAL EVALUATION OF MHC CLASS-I AND CLASS-II ANTIGEN EXPRESSION ON NEVI AND MELANOMA - RELATION TO BIOLOGY OF MELANOMA [J].
DALESSANDRO, G ;
ZARDAWI, I ;
GRACE, J ;
MCCARTHY, WH ;
HERSEY, P .
PATHOLOGY, 1987, 19 (04) :339-346
[4]  
DECHAVANNE M, 1987, THROMB HAEMOSTASIS, V57, P106
[5]   APROTININ IN CARDIOPULMONARY BYPASS - EFFECTS ON THE HAGEMAN-FACTOR (FXII) - KALLIKREIN SYSTEM AND BLOOD-LOSS [J].
FUHRER, G ;
GALLIMORE, MJ ;
HELLER, W ;
HOFFMEISTER, HE .
BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (01) :99-104
[6]  
GRAM J, 1990, THROMB HAEMOSTASIS, V63, P241
[7]  
HARKER LA, 1980, BLOOD, V56, P824
[8]  
HAVEL M, 1991, J THORAC CARDIOV SUR, V101, P968
[9]  
KLUFT C, 1992, AGENTS ACTIONS S, V35, P305
[10]  
KNOBL PN, 1987, J THORAC CARDIOV SUR, V94, P600